CN102038560A - Construction method of operation model for collecting cerebrospinal fluid repeatedly - Google Patents
Construction method of operation model for collecting cerebrospinal fluid repeatedly Download PDFInfo
- Publication number
- CN102038560A CN102038560A CN 201010610122 CN201010610122A CN102038560A CN 102038560 A CN102038560 A CN 102038560A CN 201010610122 CN201010610122 CN 201010610122 CN 201010610122 A CN201010610122 A CN 201010610122A CN 102038560 A CN102038560 A CN 102038560A
- Authority
- CN
- China
- Prior art keywords
- cerebrospinal fluid
- construction method
- drainage tube
- repeatedly
- fluid according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000001175 cerebrospinal fluid Anatomy 0.000 title claims abstract description 49
- 238000010276 construction Methods 0.000 title claims abstract description 13
- 210000003625 skull Anatomy 0.000 claims abstract description 18
- 241001465754 Metazoa Species 0.000 claims abstract description 16
- 230000002490 cerebral effect Effects 0.000 claims description 12
- 238000001356 surgical procedure Methods 0.000 claims description 11
- 210000003205 muscle Anatomy 0.000 claims description 6
- 206010002091 Anaesthesia Diseases 0.000 claims description 3
- 241000283984 Rodentia Species 0.000 claims description 3
- 230000037005 anaesthesia Effects 0.000 claims description 3
- 210000004761 scalp Anatomy 0.000 claims description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 claims 2
- 108010027529 Bio-glue Proteins 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 19
- 238000005553 drilling Methods 0.000 abstract description 7
- 230000000144 pharmacologic effect Effects 0.000 abstract description 3
- 230000004083 survival effect Effects 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 238000013461 design Methods 0.000 abstract description 2
- 238000002474 experimental method Methods 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 241000282472 Canis lupus familiaris Species 0.000 description 13
- 239000003814 drug Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 210000003128 head Anatomy 0.000 description 5
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 210000000103 occipital bone Anatomy 0.000 description 4
- 241000282465 Canis Species 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000000278 spinal cord Anatomy 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000008499 blood brain barrier function Effects 0.000 description 2
- 210000001218 blood-brain barrier Anatomy 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 210000001638 cerebellum Anatomy 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 210000002454 frontal bone Anatomy 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004279 orbit Anatomy 0.000 description 2
- 210000003455 parietal bone Anatomy 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 210000003582 temporal bone Anatomy 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000003364 biologic glue Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000003703 cisterna magna Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000001352 masseter muscle Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000002330 subarachnoid space Anatomy 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Images
Landscapes
- External Artificial Organs (AREA)
Abstract
Description
技术领域technical field
本发明涉及脑脊液采集方法领域,具体涉及一种脑脊液多次采集手术模型的构建方法。The invention relates to the field of cerebrospinal fluid collection methods, in particular to a method for constructing an operation model for multiple collection of cerebrospinal fluid.
背景技术Background technique
脑脊液(Cerebrospinal fluid,CSF)是充满在各脑室、蛛网膜下腔和脊髓中央管内的无色透明的液体,性质与血浆和淋巴液的性质相似,略带粘性,用于供应脑细胞一定的营养、运走脑组织的代谢产物、调节中枢神经系统的酸碱平衡并缓冲脑和脊髓的压力,对脑和脊髓具有保护和支持作用。因此研究药物是否能有效的通过血脑屏障可以通过检测药物在脑脊液中的含量来探索。Cerebrospinal fluid (CSF) is a colorless and transparent liquid filled in the ventricles, subarachnoid space, and central canal of the spinal cord. It is similar in nature to plasma and lymph, slightly viscous, and is used to supply certain nutrients to brain cells. , Carry away the metabolites of brain tissue, regulate the acid-base balance of the central nervous system and buffer the pressure of the brain and spinal cord, and have a protective and supportive effect on the brain and spinal cord. Therefore, whether the drug can effectively pass through the blood-brain barrier can be explored by detecting the content of the drug in the cerebrospinal fluid.
脑脊液的采集为临床试验与非临床研究共同的手术难题,脑是哺乳动物生命中枢和许多重要中枢聚集的场所,所以即使颅内富含着脑脊液,为保证生命安全,在临床试验中脑脊液的采集方法往往选择穿刺脊椎法。目前脑脊液的采集多为一次性采集,且动物模型以大、小鼠为主。在非临床研究中,大多数实验选择用穿刺针从实验动物颈部刺入,到达延髓池采集。The collection of cerebrospinal fluid is a common surgical problem in clinical trials and non-clinical research. The brain is the life center of mammals and the place where many important centers gather. Methods often choose spinal puncture method. At present, the collection of cerebrospinal fluid is mostly one-time collection, and the animal models are mainly rats and mice. In non-clinical studies, most experiments choose to use a puncture needle to pierce from the neck of experimental animals and reach the cisterna magna for collection.
在做药物在机体内的代谢动力学研究时,多采用分批采集不同个体动物的方法满足多时间点的药物数据。这种代替方法限制了药动学/药效学(PK/PD)试验的科学性。因此利用犬或其他动物建立新的类非啮齿动物脑脊液多次采集手术模型对生物医药研究显得尤为重要。When doing research on the metabolic kinetics of drugs in the body, the method of collecting different individual animals in batches is often used to meet the drug data at multiple time points. This alternative approach limits the scientific validity of pharmacokinetic/pharmacodynamic (PK/PD) studies. Therefore, using dogs or other animals to establish new non-rodent cerebrospinal fluid multiple collection surgical models is particularly important for biomedical research.
发明内容Contents of the invention
本发明提供了一种脑脊液多次采集手术模型的构建方法,该方法操作简单,易于控制,实现了对脑脊液的多次采集。The invention provides a method for constructing an operation model for multiple collections of cerebrospinal fluid. The method is simple to operate and easy to control, and realizes multiple collections of cerebrospinal fluid.
一种脑脊液多次采集手术模型的构建方法,包括以下步骤:A method for constructing a cerebrospinal fluid multiple collection operation model, comprising the following steps:
将动物麻醉后,在动物颅骨平面结构上定位手术钻孔,在所述的钻孔中经外套管穿刺针穿刺、埋入引流管并固定引流管,通过引流管多次采集脑脊液。After the animal is anesthetized, a surgical drill hole is positioned on the plane structure of the animal's skull, and the puncture needle is punctured through the outer cannula in the drill hole, a drainage tube is embedded and fixed, and cerebrospinal fluid is collected through the drainage tube multiple times.
所述的钻孔的直径不宜太大,以避免造成过大的创面,优选为2mm~5mm。The diameter of the drilled holes should not be too large to avoid excessively large wounds, preferably 2 mm to 5 mm.
为保证穿刺针顺利通过颅骨,并准确到达小脑窝,所述的钻孔对准生理狭缝,钻孔的方向应与穿刺方向一致。In order to ensure that the puncture needle passes through the skull smoothly and accurately reaches the cerebellar fossa, the drill hole is aimed at the physiological slit, and the direction of the drill hole should be consistent with the puncture direction.
所述的钻孔优选位于颅骨平面中心。The burr hole is preferably located in the center of the skull plane.
所述的外套管穿刺针穿刺前在针内填充钝头内针,针头放至已钻好的孔内,穿刺时穿刺针沿生理狭缝向下方30°~45°刺入到达小脑窝,深入约3~5cm。Before puncturing, the outer cannula puncture needle is filled with a blunt-tipped inner needle, and the needle is placed in the drilled hole. When puncturing, the puncture needle penetrates downward along the physiological slit at 30°-45° to reach the cerebellar fossa, and penetrates deep into the cerebellar fossa. About 3-5cm.
所述的穿刺针针头到达小脑窝后拔出内针,将引流管插入针孔内,固定引流管将穿刺针缓缓拔出,用医用生物胶固定引流管颅骨外端部分,露出数厘米引流管以备采集脑脊液,缝合肌肉和头皮,保证引流管固定牢固,内部通畅。犬术后恢复12小时以上。After the needle head of the puncture needle reaches the cerebellar fossa, pull out the inner needle, insert the drainage tube into the needle hole, fix the drainage tube and slowly pull out the puncture needle, fix the outer end of the skull of the drainage tube with medical biological glue, and expose several centimeters of drainage The tube was prepared for collecting cerebrospinal fluid, and the muscles and scalp were sutured to ensure that the drainage tube was firmly fixed and the interior was unobstructed. Dogs recover for more than 12 hours after surgery.
所述的引流管可选用引流聚乙烯塑料(PE)管。The drainage tube can be selected as drainage polyethylene plastic (PE) tube.
所述的动物为非啮齿类动物,优选为犬。Said animals are non-rodent animals, preferably dogs.
所述的采集脑脊液的时间为动物恢复12小时以上,采集脑脊液所用的装置可为注射器等抽取式装置。The time for collecting cerebrospinal fluid is more than 12 hours after the animal recovers, and the device used for collecting cerebrospinal fluid can be a suction device such as a syringe.
与现有技术相比,本发明具有如下优点:Compared with prior art, the present invention has following advantage:
本发明方法实现了在小脑窝处采集脑脊液,因为小脑窝是颅内一个较大的空腔,其储存脑脊液能力相对较高;并且小脑窝为颅骨最下端的低洼空腔,手术钻孔在颅骨上方,因此无论动物清醒状态或是麻醉状态脑脊液都不会因手术缺口而流失。The method of the present invention realizes the collection of cerebrospinal fluid at the cerebellar fossa, because the cerebellar fossa is a relatively large cavity in the skull, and its ability to store cerebrospinal fluid is relatively high; Therefore, no matter whether the animal is awake or anesthetized, the cerebrospinal fluid will not be lost due to the surgical gap.
本发明方法为毒代、药代等药理试验提供了更加有效合理的脑脊液采集新模型,实现了对脑脊液的多次采集。该方法中动物的手术存活率可达80%,模型成功率可达60%,说明该模型构建方法设计合理,有利于脑脊液的多次采集。The method of the invention provides a more effective and reasonable new model for collecting cerebrospinal fluid for pharmacological tests such as toxicology and pharmacokinetics, and realizes multiple collections of cerebrospinal fluid. In this method, the surgical survival rate of animals can reach 80%, and the success rate of the model can reach 60%, which shows that the design of the model construction method is reasonable, and it is beneficial to the multiple collection of cerebrospinal fluid.
附图说明Description of drawings
图1为犬头部骨骼的俯视结构示意图;Fig. 1 is the top view structure schematic diagram of canine head skeleton;
图2为犬头部骨骼的侧面结构示意图;Figure 2 is a schematic diagram of the side structure of the dog's head skeleton;
其中,1为额骨;2为颧骨颞突;3为眼窝;4为顶间骨;5为顶骨;6为钻孔处;7为颞骨颧突;8为咬肌窝;9为部分小脑窝;10为剩余小脑窝。Among them, 1 is the frontal bone; 2 is the temporal process of the zygomatic bone; 3 is the eye socket; 4 is the interparietal bone; 5 is the parietal bone; 6 is the drilling site; 7 is the zygomatic process of the temporal bone; Fossa; 10 is the remaining cerebellar fossa.
具体实施方式Detailed ways
现将本发明的具体实施例进一步叙述于后。Specific embodiments of the present invention are further described below.
实施例1Example 1
如图1和图2所示,犬头部骨骼的结构包括:额骨1;颧骨颞突2;眼窝3;顶间骨4;顶骨5;钻孔处6;颞骨颧突7;咬肌窝8;小脑窝9和10。As shown in Figure 1 and Figure 2, the structure of the canine head skeleton includes:
Beagle犬静脉注射3%的戊巴比妥钠溶液(1ml/kg)麻醉后,俯卧固定于手术台上。喉咙处用软枕垫起使枕骨朝上,固定Beagle犬头部。以Beagle犬枕骨为中心,将犬枕骨左后侧毛剃去。用手术刀在离枕骨2~3cm处剃毛区域划开一条2cm左右的横向切口。用手术分离器械钝性分离犬颅骨平面上方筋膜暴露颅骨上方肌肉群。顺着肌肉纹路垂直颅骨平面向下分离肌肉直至颅骨暴露。确定颅骨平面中心即钻孔处6,用颅骨钻在中心钻出2~5mm的孔,孔周围为直径2cm左右的颅骨平面。为保证穿刺针顺利通过颅骨,并准确到达小脑窝9或10,钻孔方向应与穿刺方向一致,钻孔对准生理狭缝,犬脑组织中小脑与大脑链接处为生理狭缝。Beagle dogs were anesthetized by intravenous injection of 3% pentobarbital sodium solution (1ml/kg), and fixed on the operating table in prone position. The throat is padded with a soft pillow so that the occipital bone is facing up, and the head of the Beagle dog is fixed. With the Beagle dog occipital bone as the center, the hair on the left rear side of the dog occipital bone was shaved. Use a scalpel to make a transverse incision of about 2 cm in the shaved area 2 to 3 cm away from the occipital bone. The fascia above the plane of the dog's skull was bluntly dissected with a surgical dissection instrument to expose the muscle group above the skull. Separate the muscles vertically to the plane of the skull along the muscle lines until the skull is exposed. Determine the center of the skull plane, that is, the drilling site 6, drill a hole of 2-5 mm in the center with a skull drill, and surround the hole with a skull plane with a diameter of about 2 cm. In order to ensure that the puncture needle passes through the skull smoothly and accurately reaches the cerebellar fossa 9 or 10, the drilling direction should be consistent with the puncture direction, and the drilling should be aimed at the physiological slit, which is the link between the cerebellum and the brain in the canine brain tissue.
使用外套管外径为1.6mm穿刺针,穿刺前在针内填充钝头内针,针头放至已钻好的孔内,穿刺时穿刺针沿生理狭缝向下方30~45°刺入到达小脑窝,深入约3~5cm。Use a puncture needle with an outer cannula diameter of 1.6mm, fill the needle with a blunt inner needle before puncture, put the needle into the drilled hole, and penetrate the cerebellum 30-45° downward along the physiological slit during puncture Nest, about 3 to 5 cm deep.
当穿刺针头到达小脑窝后拔出内针,可以看见脑脊液从针孔中溢出(颅内压作用)。将引流管插入针孔内,固定引流管将穿刺针缓缓拔出,用医用生物蛋白胶固定引流管颅骨外端部分,露出数厘米引流管以备采集脑脊液。手术部位洒入抗生素,缝合肌肉和头皮,麻醉状态下头部低位放置。封住引流管开口端,防止脑脊液外溢。术后隔日伤口护理。When the puncture needle reaches the cerebellar fossa, the inner needle can be pulled out, and the cerebrospinal fluid can be seen overflowing from the needle hole (the effect of intracranial pressure). Insert the drainage tube into the needle hole, fix the drainage tube and slowly pull out the puncture needle, fix the outer part of the skull of the drainage tube with medical bio-protein glue, and expose a few centimeters of the drainage tube for the collection of cerebrospinal fluid. Antibiotics are sprinkled on the surgical site, the muscles and scalp are sutured, and the head is placed in a low position under anesthesia. Seal the open end of the drainage tube to prevent cerebrospinal fluid from overflowing. Wound care the next day after surgery.
术后12小时,打开引流管封口,将注射器插入引流管,抽取50μl管内液体舍去。待脑脊液自行从引流管渗出;即时采取脑脊液可用注射器缓慢抽取。术后每日抽取脑脊液用于检查脑脊液手术成功率,共观察7天。抽取量设置为:第1天(术后麻醉状态分点采集)4.5ml;清醒后0.5ml;其余13天每天抽取0.5ml。Twelve hours after the operation, the seal of the drainage tube was opened, a syringe was inserted into the drainage tube, and 50 μl of liquid in the tube was drawn and discarded. Wait for the cerebrospinal fluid to seep out from the drainage tube by itself; immediately take the cerebrospinal fluid and slowly draw it with a syringe. Cerebrospinal fluid was extracted daily after operation to check the success rate of cerebrospinal fluid operation, and observed for 7 days. The extraction volume is set as follows: 4.5ml on the first day (point-based collection under postoperative anesthesia); 0.5ml after waking up; and 0.5ml per day for the remaining 13 days.
手术成功率以Beagle犬术后健康存活为准。模型成功率通过术后Beagle犬可连续采集不被血液污染脑脊液为成功标准。10只Beagle犬手术,手术成功率80%。手术后每日采集脑脊液,7天均可顺利采集到脑脊液,模型成功率为60%。The success rate of the operation is based on the postoperative healthy survival of Beagle dogs. The success rate of the model is that the continuous collection of cerebrospinal fluid without blood contamination by Beagle dogs after the operation is the success criterion. 10 Beagle dogs were operated on, and the success rate of the operation was 80%. The cerebrospinal fluid was collected every day after the operation, and the cerebrospinal fluid could be collected smoothly within 7 days, and the success rate of the model was 60%.
实施例2Example 2
如实施例1中所述方法构建模型动物4只。取某可穿透血脑屏障的药物乙二胺(EDA)注射液,药物配置于质量百分浓度为0.9%的NaCl注射液中,按药物1mg/kg/h的速度静脉滴注至3h。并在给药0、30、60和180min(给药结束)及停药后0.5、1、2、3和4h定时采取2ml全血和0.3ml脑脊液。应用所建立的方法检测生物样品中的EDA浓度。应用DAS 2.0药代动力学软件分析结果。由药动学结果可知,在以静脉滴注方式给予Beagle犬3mg/kg药物后,EDA以三室模型的方式消除。Four model animals were constructed as described in Example 1. Take a drug ethylenediamine (EDA) injection that can penetrate the blood-brain barrier, configure the drug in NaCl injection with a concentration of 0.9% by mass, and infuse it intravenously for 3 hours at a rate of 1 mg/kg/h. 2ml of whole blood and 0.3ml of cerebrospinal fluid were regularly collected at 0, 30, 60, and 180 minutes after administration (end of administration) and 0.5, 1, 2, 3, and 4 hours after drug withdrawal. The established method was applied to detect the EDA concentration in biological samples. The results were analyzed using DAS 2.0 pharmacokinetic software. According to the results of pharmacokinetics, EDA was eliminated in a three-compartment model after intravenous infusion of 3 mg/kg to Beagle dogs.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010610122 CN102038560A (en) | 2010-12-28 | 2010-12-28 | Construction method of operation model for collecting cerebrospinal fluid repeatedly |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010610122 CN102038560A (en) | 2010-12-28 | 2010-12-28 | Construction method of operation model for collecting cerebrospinal fluid repeatedly |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102038560A true CN102038560A (en) | 2011-05-04 |
Family
ID=43905339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010610122 Pending CN102038560A (en) | 2010-12-28 | 2010-12-28 | Construction method of operation model for collecting cerebrospinal fluid repeatedly |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102038560A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102784012A (en) * | 2012-03-16 | 2012-11-21 | 中山大学 | Blood brain barrier pharmacokinefic continuous dosing system and detecting system |
CN103598924A (en) * | 2013-12-03 | 2014-02-26 | 菏泽学院 | Experiment rat central nervous sucking and pulling device |
CN104323868A (en) * | 2014-11-06 | 2015-02-04 | 中国人民解放军第四军医大学 | Micro-infusion method and device thereof based on epididymis duct intracavity environment experiment |
CN117224267A (en) * | 2023-11-10 | 2023-12-15 | 北京伽拓医药研究有限公司 | Method for establishing canine frontal sinus defect and cerebrospinal fluid rhinorrhea model and application thereof |
-
2010
- 2010-12-28 CN CN 201010610122 patent/CN102038560A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102784012A (en) * | 2012-03-16 | 2012-11-21 | 中山大学 | Blood brain barrier pharmacokinefic continuous dosing system and detecting system |
CN102784012B (en) * | 2012-03-16 | 2015-05-06 | 中山大学 | Blood brain barrier pharmacokinefic continuous dosing system and detecting system |
CN103598924A (en) * | 2013-12-03 | 2014-02-26 | 菏泽学院 | Experiment rat central nervous sucking and pulling device |
CN103598924B (en) * | 2013-12-03 | 2015-09-09 | 菏泽学院 | Experimental rat central nervous system suction device |
CN104323868A (en) * | 2014-11-06 | 2015-02-04 | 中国人民解放军第四军医大学 | Micro-infusion method and device thereof based on epididymis duct intracavity environment experiment |
CN117224267A (en) * | 2023-11-10 | 2023-12-15 | 北京伽拓医药研究有限公司 | Method for establishing canine frontal sinus defect and cerebrospinal fluid rhinorrhea model and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1511052A (en) | Combined needle and dilator device for central venous and arterial cathe terization | |
CN102038560A (en) | Construction method of operation model for collecting cerebrospinal fluid repeatedly | |
CN103285501A (en) | An intelligent positioning bone marrow transfusion puncture system | |
CN102784012B (en) | Blood brain barrier pharmacokinefic continuous dosing system and detecting system | |
CN104921762B (en) | A kind of scope for airway wall punctures sampling probe | |
CN109394237A (en) | A kind of blood-taking device and its control equipment | |
JP6938064B2 (en) | Puncture needle, puncture needle kit and stereotactic brain surgery device | |
CN208319233U (en) | A kind of internal medicine puncture needle | |
CN114848218A (en) | Method for establishing mouse lateral ventricle drug delivery model | |
CN209032563U (en) | A kind of nerve block needle | |
CN208741025U (en) | A neonatal multifunctional safety type lumbar puncture catheter needle with scale | |
JP2004344299A (en) | Bone marrow automatic perfusion collection method and apparatus | |
CN208193186U (en) | Rat inflammation soup stimulates model | |
CN206403836U (en) | A kind of mammary subcutaneous effusion drainage device | |
CN102008329A (en) | Method for rapidly and simply collecting rat cerebrospinal fluid | |
CN221383906U (en) | Heart perfusion needle for experimental animal | |
CN204745325U (en) | Transfusion system in bone | |
CN211066933U (en) | Ultrasonic guide nerve blocking needle structure | |
CN2715779Y (en) | Single chamber double hole needle for extradural and spinal cord united anaesthesia | |
CN222853889U (en) | SAKI blood collection device for model construction | |
CN213489176U (en) | Safe porous supersound puncture drainage needle | |
CN203059867U (en) | Special puncture needle for department of cardiology | |
CN101301227A (en) | Methods of catheterization in epidural space and subarachnoid space in rats | |
CN210250011U (en) | Puncture needle | |
CN2776414Y (en) | Multifunction encephalocoele external drain device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20110504 |